Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Molecules (Basel, Switzerland)
|
November 6, 2020
Gelatin-Modified Calcium/Strontium Hydrogen Phosphates Stimulate Bone Regeneration in Osteoblast/Osteoclast Co-Culture and in Osteoporotic Rat Femur Defects-In Vitro to In Vivo Translation
Benjamin Kruppke, Seemun Ray, Volker Alt, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137
Athina Zerva, Nicolai D Raig, Zaile Zhuang, et al.
Journal of Medicinal Chemistry
|
November 1, 2013
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo
Thomas Hanke, Friederike Dehm, Stefanie Liening, et al.
Journal of Medicinal Chemistry
|
May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles
Christian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
December 21, 2023
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3
Jennifer Alisa Amrhein, Lena Marie Berger, Dimitrios-Ilias Balourdas, et al.
Plos One
|
October 17, 2013
Podoplanin immunopositive lymphatic vessels at the implant interface in a rat model of osteoporotic fractures
Katrin Susanne Lips, Vivien Kauschke, Sonja Hartmann, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Journal of Medicinal Chemistry
|
April 9, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode
Thomas Hanke, Sun-Yee Cheung, Whitney Kilu, et al.
Nature Immunology
|
February 8, 2005
Crystal structure of a soluble CD28-Fab complex
Edward J Evans, Robert M Esnouf, Raquel Manso-Sancho, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Molecules (Basel, Switzerland)
|
November 6, 2020
Gelatin-Modified Calcium/Strontium Hydrogen Phosphates Stimulate Bone Regeneration in Osteoblast/Osteoclast Co-Culture and in Osteoporotic Rat Femur Defects-In Vitro to In Vivo Translation
Benjamin Kruppke, Seemun Ray, Volker Alt, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137
Athina Zerva, Nicolai D Raig, Zaile Zhuang, et al.
Journal of Medicinal Chemistry
|
November 1, 2013
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo
Thomas Hanke, Friederike Dehm, Stefanie Liening, et al.
Journal of Medicinal Chemistry
|
May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles
Christian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
December 21, 2023
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3
Jennifer Alisa Amrhein, Lena Marie Berger, Dimitrios-Ilias Balourdas, et al.
Plos One
|
October 17, 2013
Podoplanin immunopositive lymphatic vessels at the implant interface in a rat model of osteoporotic fractures
Katrin Susanne Lips, Vivien Kauschke, Sonja Hartmann, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Journal of Medicinal Chemistry
|
April 9, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode
Thomas Hanke, Sun-Yee Cheung, Whitney Kilu, et al.
Nature Immunology
|
February 8, 2005
Crystal structure of a soluble CD28-Fab complex
Edward J Evans, Robert M Esnouf, Raquel Manso-Sancho, et al.
Page
of 11